longevity science
Longevity Science vs Hype - Proven Trials Cut Risk
In 2024, a Nature Aging analysis reported a 32% drop in senescent cell burden after one month of BCL-x inhibition. Proven, peer-reviewed trials are the surest way to cut risk when evaluating longevity companies, because they separate real science from hype. Medical Disclaimer: This article is for informational purposes only